Evidence map›Paper›PMID 40550843›Full record

ArticleCommunications biology2025

Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability.

Wolfgang Sadee, Ian H Cheeseman, Audrey Papp, Maciej Pietrzak, Michal Seweryn, Xiaofei Zhou, Shili Lin, Amanda M Williams, Mark D Wewers, Heather M Curry and 12 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Restricted MHC-II trafficking inbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Peptide-Based Strategies AgainstPharmaceuticals (Basel, Switzerland) · 2025
    Review
  12. Genes required forbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Frontiers in immunology · 2025
    Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Wolfgang Sadee *Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, USA. wolfgang.sadee@gmail.com.ORCID http://orcid.org/0000-0003-1894-6374
Ian H Cheeseman *Texas Biomedical Research Institute, San Antonio, TX, USA.ORCID http://orcid.org/0000-0003-4426-4027
Audrey PappDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, USA.
Maciej PietrzakDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.
Michal SewerynBiobank Lab, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Łódź, Łódź, Poland.
Xiaofei ZhouDepartment of Statistics, College of Arts and Sciences, The Ohio State University, Columbus, OH, USA.
Shili LinDepartment of Statistics, College of Arts and Sciences, The Ohio State University, Columbus, OH, USA.
Amanda M WilliamsDepartment of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH, USA.
Mark D WewersDepartment of Internal Medicine, Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, The Ohio State University, Columbus, OH, USA.
Heather M CurryQED Biosciences, Inc., San Diego, CA, USA.
Hao ZhangDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX, USA.
Hong CaiDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX, USA.
Carine Kunsevi-KilolaDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
Happy TshivhulaDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
Gerhard WalzlDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
Blanca I RestrepoDepartment of Epidemiology, School of Public Health, University of Texas Health Science Center at Houston, Brownsville campus, Brownsville, TX, USA.ORCID http://orcid.org/0000-0002-3743-9098
Léanie KleynhansDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0003-1635-253X
Katharina RonacherDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-6371-1462
Yufeng WangDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX, USA.
Eusondia ArnettTexas Biomedical Research Institute, San Antonio, TX, USA.ORCID http://orcid.org/0009-0004-5259-7117
Abul K AzadTexas Biomedical Research Institute, San Antonio, TX, USA.
Larry S SchlesingerTexas Biomedical Research Institute, San Antonio, TX, USA. lschlesinger@txbiomed.org.ORCID http://orcid.org/0000-0002-7177-8421

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
Expression Genetics in Drug TherapyU01GM092655 · NIGMS · OHIO STATE UNIVERSITY · PI SADEE, WOLFGANG · 2010 to 2014
$8.6M
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection- Diversity SupplementR01AI136831 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Eusondia A. Arnett, Larry S. Schlesinger · 2019 to 2026
$4.6M
Altered immune-endocrine axis in type 2 diabetes and tuberculosis riskR01AI116039 · NIAID · STELLENBOSCH UNIVERSITY · PI KLEYNHANS, LEANIE, RESTREPO, BLANCA I · 2015 to 2019
$1.7M
Illumina NovaSeq 6000 Sequencing SystemS10OD030311 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LAI, ZHAO · 2021 to 2021
$600k
NCI NIH HHS P30 CA054174NIAID NIH HHS R01 AI116039NIAID NIH HHS R01 AI136831NIGMS NIH HHS U01 GM092655NIH HHS S10 OD030311
6 · The paper itself

Abstract

Mycobacterium tuberculosis (M.tb) infection infects human alveolar macrophages (HAMs). In freshly isolated HAMs from 28 healthy adults, we observe large inter-individual differences in bacterial uptake and growth, with tenfold variation in M.tb load by 72 h. While M.tb infection triggers expression changes of numerous host mRNAs, we examined which genes are most variably expressed (VE genes) between donors, as potential biomarkers of individual tuberculosis (TB) risk. The HAM RNA transcriptome following infection revealed thousands of differentially expressed (DE) genes and differential secretion of 25/27 proteins. Yet only 324 DE genes represent VE genes detected exclusively among DE genes in infected cells. Of 36 DE genes detected at all time points (2, 24, and 72 h), 14 are VE genes, indicating early emergence of the VE gene profile. 9/27 DE proteins following infection were encoded by VE genes. Systems analysis of VE RNAs identified a top-scoring network anchored by IL1B, involved in TB immune response. Independent M.tb-HAM transcriptome results from a TB-endemic region show significant overlap in DE genes, including VE genes identified in the main study. Thus, we identify a VE gene network activated upon M.tb-HAM infection with high inter-person variability, guiding studies on determining individual risk of M.tb infection and/or disease.

Indexed as

Macrophages, AlveolarMycobacterium tuberculosisTuberculosisAdultFemaleGene Expression ProfilingHumansMaleMiddle AgedTranscriptome

Identifiers

PMID40550843
PMCPMC12185700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.